{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362825893851370752.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1016/0378-5173(90)90185-7"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:0378517390901857?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:0378517390901857?httpAccept=text/plain"}}],"dc:title":[{"@value":"Physicochemical characterization of furosemide modifications"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382825893851370752","@type":"Researcher","foaf:name":[{"@value":"Y MATSUDA"}]},{"@id":"https://cir.nii.ac.jp/crid/1382825893851370753","@type":"Researcher","foaf:name":[{"@value":"E TATSUMI"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"03785173"}],"prism:publicationName":[{"@value":"International Journal of Pharmaceutics"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"1990-04-20","prism:volume":"60","prism:number":"1","prism:startingPage":"11","prism:endingPage":"26"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:0378517390901857?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:0378517390901857?httpAccept=text/plain"}],"createdAt":"2002-12-14","modifiedAt":"2019-04-01","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360567182158843264","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"In situ monitoring of cocrystals in formulation development using low-frequency Raman spectroscopy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204178172416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Investigation of Discoloration of Furosemide Tablets in a Light-Shielded Environment"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001277344336000","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Improving the Solid-State Photostability of Furosemide by Its Cocrystal Formation"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001288096111104","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Novel Strategy for the Systemic Delivery of Furosemide Based on a New Drug Transport Mechanism"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679145855616","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Physicochemical Characterization of Tamoxifen Citrate Pseudopolymorphs, Methanolate and Ethanolate"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679752765312","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effect of Colored Press-Through Package (PTP) Material on Photostability of Furosemide Tablets"},{"@language":"ja","@value":"フロセミド錠の光安定性に及ぼす着色ＰＴＰ包装材料の影響"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1016/0378-5173(90)90185-7"},{"@type":"CROSSREF","@value":"10.1248/cpb.c18-00812_references_DOI_MOL1bomeibhHODungqjeph6Z1r0"},{"@type":"CROSSREF","@value":"10.1248/bpb.b18-00315_references_DOI_MOL1bomeibhHODungqjeph6Z1r0"},{"@type":"CROSSREF","@value":"10.5649/jjphcs.35.395_references_DOI_MOL1bomeibhHODungqjeph6Z1r0"},{"@type":"CROSSREF","@value":"10.1248/cpb.c16-00835_references_DOI_MOL1bomeibhHODungqjeph6Z1r0"},{"@type":"CROSSREF","@value":"10.1016/j.ijpharm.2018.03.008_references_DOI_MOL1bomeibhHODungqjeph6Z1r0"},{"@type":"CROSSREF","@value":"10.1248/cpb.55.407_references_DOI_MOL1bomeibhHODungqjeph6Z1r0"}]}